The identification of orally bioavailable thrombopoietin agonists
Authors:
- Amy S. AntipasAAAmy S. Antipas
- Laura C. BlumbergLBLaura C. Blumberg
- William H. BrissetteWBWilliam H. Brissette
- Matthew F. BrownMBMatthew F. Brown
- Jeffrey M. CasavantJCJeffrey M. Casavant
- Jonathan L. DotyJDJonathan L. Doty
- James DriscollJDJames Driscoll
- Thomas M. HarrisTHThomas M. Harris
- Lilli A. Wolf-GouveiaLWLilli A. Wolf-Gouveia
- Christopher S. JonesCJChristopher S. Jones
- Qifang LiQLQifang Li
- 1 March 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (5) , 1428-1430
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Discovery and biological evaluation of benzo[a]carbazole-based small molecule agonists of the thrombopoietin (Tpo) receptorBioorganic & Medicinal Chemistry Letters, 2008
- Optimization of small molecule agonists of the thrombopoietin (Tpo) receptor derived from a benzo[a]carbazole hit scaffoldBioorganic & Medicinal Chemistry Letters, 2008
- Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonistsBioorganic & Medicinal Chemistry Letters, 2008
- Novel Thrombopoietic AgentsDrugs, 2008
- A Rational Chemical Intervention Strategy To Circumvent Bioactivation Liabilities Associated with a Nonpeptidyl Thrombopoietin Receptor Agonist Containing a 2-Amino-4-arylthiazole MotifChemical Research in Toxicology, 2007
- Pyrimidine benzamide-based thrombopoietin receptor agonistsBioorganic & Medicinal Chemistry Letters, 2007
- EltrombopagDrugs of the Future, 2006
- A Comparison of Physiochemical Property Profiles of Development and Marketed Oral DrugsJournal of Medicinal Chemistry, 2003